| Literature DB >> 31585969 |
Ayesha Sania1, Christopher R Sudfeld2, Goodarz Danaei3, Günther Fink4, Dana C McCoy5, Zhaozhong Zhu6, Mary C Smith Fawzi7, Mehmet Akman8, Shams E Arifeen9, Aluisio J D Barros10, David Bellinger11, Maureen M Black12, Alemtsehay Bogale13, Joseph M Braun14, Nynke van den Broek15, Verena Carrara16, Paulita Duazo17, Christopher Duggan18, Lia C H Fernald19, Melissa Gladstone20, Jena Hamadani9, Alexis J Handal21, Siobán Harlow22, Melissa Hidrobo23, Chris Kuzawa24, Ingrid Kvestad25, Lindsey Locks26, Karim Manji27, Honorati Masanja28, Alicia Matijasevich29, Christine McDonald30, Rose McGready31,32, Arjumand Rizvi33, Darci Santos34, Leticia Santos34, Dilsad Save35, Roger Shapiro36, Barbara Stoecker37, Tor A Strand38, Sunita Taneja39, Martha-Maria Tellez-Rojo40, Fahmida Tofail41, Aisha K Yousafzai2, Majid Ezzati42, Wafaie Fawzi43.
Abstract
OBJECTIVE: To determine the magnitude of relationships of early life factors with child development in low/middle-income countries (LMICs).Entities:
Keywords: SGA; access to clean water; access to sanitation; breast feeding; cognitive development; diarrhoea; early life risk factors; language development; maternal anaemia and anaemia in infancy; maternal education; maternal short stature; motor development; paternal education; preterm
Mesh:
Year: 2019 PMID: 31585969 PMCID: PMC6797384 DOI: 10.1136/bmjopen-2018-026449
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flowchart of study selection.
Characteristics of the included studies
| Study | Setting | Primary study design | Study population | N | Child development tool used | Child age in years at assessment (mean±SD) | |
|
| |||||||
| 1 | Black | Bangladesh | Randomised controlled trial | Birth cohort | 221 | Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) and the Home Observation for Measurement of the Environment (HOME) Inventory | 1.06±0.03 |
| 2 | Tofail | Bangladesh | Randomised controlled trial | Birth cohort | 2853 total (2116 tested) | Two problem-solving tests, motor index of Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) and Wolke’s behaviour ratings | 0.61±0.02 |
| 3 | Tofail | Bangladesh | Randomised controlled trial | Prospective, community-based cohort | 249 | Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) | 0.84±0.01 |
| 4 | Taneja | India | Randomised placebo-controlled trial | Prospective, community-based cohort | 571 | Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) | 1.25±0.16 |
| 5 | Kvestad | India | Randomised placebo-controlled trial | Prospective, community-based cohort | 422 | Ages and Stages Questionnaire, 3rd edition (ASQ-3) | 1.37±0.60 |
| 6 | Yousafzai | Pakistan | Community-based cluster-randomised effectiveness trial | Prospective, community-based cohort | 1357 | Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) | 11.6±0.83 |
| 7 | Duazo | Philippines | Longitudinal programme evaluation | Birth cohort | 4904 | Philippines Revised Early Childhood Development Checklist (REC) | 1.62±0.88 |
| 8 | Villegas | Thailand | Randomised controlled trial | Prospective, facility-based cohort | 503 | Shoklo Developmental Test | 1.62±0.02 |
|
| |||||||
| 9 | Shapiro | Botswana | Randomised controlled trial | Prospective, community-based cohort | 224 | Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) | 2.03±0.08 |
| 10 | Bogale | Ethiopia | Cross-sectional study | Cross-sectional, community-based cohort | 100 | Raven's Coloured Progressive Matrices (CPM) and Kaufman Assessment Battery for Children-II (KABC-II) | 5.11±0.24 |
| 11 | Gladstone | Malawi | Cross-sectional community-based cohort study | Community-based cohort | 840 | Ten Question Questionnaire (TQQ) and Malawi Developmental Assessment Tool (MDAT) | 1.74±0.33 |
| 12 | McDonald | Tanzania | Randomised placebo-controlled trial | Birth cohort | 305 | Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) | 1.28±0.04 |
| 13 | Manji | Tanzania | Randomised placebo-controlled trial | Birth cohort | 206 | Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) | 1.28±0.04 |
| 14 | Sudfeld | Tanzania | Randomised placebo-controlled trial | Birth cohort | 958 | Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) | 2.25±0.52 |
| 15 | Locks | Tanzania | Randomised placebo-controlled trial | Birth cohort | 248 | Bayley Scales of Infant and Toddler Development, 3rd edition (BSID-III) | 1.21±0.03 |
|
| |||||||
| 16 | Santos | Brazil | Longitudinal birth cohort survey | 2004 Pelotas birth cohort | 3868 | Battelle Screening Developmental Inventory (BSDI) | 1.99±0.05 |
| 17 | Santos | Brazil | Longitudinal birth cohort survey | Longitudinal, community-based cohort | 365 | Wechsler Pre-School and Primary | 5.80±3.02 |
| 18 | Fernald | Ecuador | Randomised effectiveness trial | Prospective, community-based cohort | 1265 | MacArthur-Bates Communicative Development Inventory, short form, Spanish version | 4.59±0.87 |
| 19 | Handal | Ecuador | Cross-sectional | Community based, selected using door-to-door survey | 283 | Ages and Stages Questionnaire | 2.46±1.46 |
| 20 | Braun | Mexico | Prospective cohort study | Prospective, facility-based cohort | 1032 | Bayley Scales of Infant and Toddler Development, 2nd edition (BSID-II) McCarthy Scales of Children’s Abilities (MSCA) | 2.02±0.03 |
|
| |||||||
| 21 | Akman | Europe-Turkey | Randomised clinical trial | Facility-based hospital | 108 | Bayley Scales of Infant and Toddler Development, 1st edition (BSID-I) | 1.42±0.59 |
Summary results of meta-analysis of associations of parental factors and cognitive, motor and language developments
| Risk factor | Cognitive | Motor | Language | |||||||||
| No of studies | Adjusted* | P value | I2 (%) | No of studies | Adjusted* | P value | I2 (%) | No of studies | Adjusted* | P value | I2 (%) | |
|
| ||||||||||||
| No education (<1 years) | 15 | −0.12 (–0.24 to –0.008) | 0.05 | 50.8 | 18 | −0.07 (–0.13 to –0.01) | 0.03 | 18.2 | 5 | −0.06 (–0.21 to –0.09) | 0.49 | 35.5 |
| Primary (1- <6 years) | Reference | Reference | Reference | |||||||||
| Secondary (6- <10 years) | 17 | 0.14 (0.05 to 0.24) | <0.01 | 59.7 | 19 | 0.12 (0.06 to 0.18) | <0.01 | 51.8 | 5 | 0.13 (0.04 to 0.21) | 0.04 | 0.0 |
| Higher (≥10 years) | 17 | 0.36 (0.19 to 0.48) | <0.01 | 65.8 | 19 | 0.26 (0.14 to 0.38) | <0.01 | 70.6 | 5 | 0.21 (0.09 to 0.33) | 0.03 | 0.0 |
|
| ||||||||||||
| No education (<1 years) | 13 | −0.005 (–0.08 to 0.07) | 0.91 | 0.0 | 17 | −0.08 (–0.11 to –0.04) | <0.01 | 0.0 | 4 | 0.02 (–0.15 to 0.20) | 0.80 | 30.0 |
| Primary (1- <6 years) | Reference | Reference | Reference | |||||||||
| Secondary (6- <10 years) | 15 | 0.06 (0.015 to 0.11) | 0.02 | 0.0 | 17 | 0.08 (0.03 to 0.13) | <0.01 | 30.3 | 4 | 0.09 (0.02 to 0.16) | 0.08 | 0.0 |
| Higher (≥10 years) | 15 | 0.15 (0.08 to 0.21) | <0.01 | 0.0 | 17 | 0.18 (0.10 to 0.26) | <0.01 | 42.3 | 4 | 0.22 (0.11 to 0.32) | 0.03 | 17.9 |
|
| ||||||||||||
| <15 | 5 | −0.06 (–0.13 to 0.25) | 0.57 | 0.0 | 5 | 0.12 (–0.06 to 0.30) | 0.25 | 0.0 | 2 | n/a | n/a | n/a |
| 15- <20 years | 18 | −0.007 (–0.06 to 0.05) | 0.80 | 10.7 | 20 | −0.02 (–0.11 to 0.08) | 0.75 | 83.6 | 6 | 0.01 (–0.09 to 0.11) | 0.85 | 37.0 |
| 20–34 years | Reference | Reference | Reference | |||||||||
| ≥35 years | 18 | −0.01 (–0.06 to 0.04) | 0.58 | 0.0 | 20 | −0.006 (–0.07 to 0.05) | 0.85 | 50.1 | 6 | 0.02 (–0.05 to 0.09) | 0.59 | 0.0 |
|
| ||||||||||||
| <145 cm | 11 | −0.10 (–0.20 to –0.004) | 0.07 | 0.0 | 13 | −0.11 (–0.19 to –0.03) | 0.02 | 21.5 | 5 | −0.11 (–0.31 to 0.09) | 0.35 | 0.0 |
| 145- <150 cm | 13 | −0.11 (–0.19 to –0.02) | 0.03 | 27.1 | 15 | −0.07 (–0.16 to 0.03) | 0.17 | 71.1 | 5 | −0.06 (–0.13 to 0.06) | 0.52 | 0.0 |
| 150- <155 cm | 13 | −0.09 (–0.14 to –0.04) | <0.01 | 3.3 | 15 | −0.04 (–0.09 to 0.009) | 0.14 | 31.5 | 5 | −0.05 (–0.12 to 0.02) | 0.22 | 0.0 |
| >155 cm | Reference | Reference | Reference | |||||||||
|
| ||||||||||||
| <18.5 | 11 | −0.11 (-0.20 to -0.02) | 0.03 | 12.7 | 13 | −0.02 (-0.11 to 0.07) | 0.69 | 51.4 | 3 | n/a | n/a | n/a |
| 18.5- <25 | Reference | Reference | Reference | |||||||||
| 25- <30 | 12 | 0.03 (-0.04 to 0.09) | 0.44 | 23.3 | 14 | 0.04 (-0.03 to 0.11) | 0.31 | 64.6 | 4 | −0.04 (-0.21 to 0.13) | 0.70 | 61.0 |
| ≥30 | 12 | −0.02 (-0.17 to 0.14) | 0.82 | 46.3 | 14 | −0.02 (-0.14 to 0.10) | 0.77 | 63.6 | 4 | −0.14 (-0.34 to 0.06) | 0.26 | 35.9 |
|
| ||||||||||||
| Normal (≥110 g/L)) | Reference | Reference | Reference | |||||||||
| Mild anaemia (100–109 g/L) | 4 | −0.06 (-0.15 to 0.03) | 0.28 | 0.0 | 11 | 0.06 (0.008 to 0.11) | 0.04 | 29.7 | 1 | n/a | n/a | n/a |
| Moderate anaemia | 4 | −0.06 (-0.19 to 0.06) | 0.39 | 0.0 | 6 | −0.01 (-0.06 to 0.04) | 0.68 | 16.3 | 1 | n/a | n/a | n/a |
*Adjusted for child’s gender and age, mother’s education and household wealth.
BMI, body mass index; SMD, standardised mean difference.
Summary results of meta-analysis of associations of child factors and cognitive, motor and language developments, standardised scores
| Risk factor | Cognitive | Motor | Language | |||||||||
| No of studies | Adjusted* | P value | I† (%) | No of studies | Adjusted* | P value | I† (%) | No of studies | Adjusted* | P value | I† (%) | |
|
| ||||||||||||
| Normal (≥2500 g) | Reference | Reference | Reference | |||||||||
| Low (<2500 g) | 14 | −0.13 (−0.20 to −0.07) | <0.01 | 51.0 | 15 | −0.14 (−0.23 to −0.06) | <0.01 | 66.5 | 5 | −0.11 (−0.22 to 0.00) | 0.12 | 74.6 |
| Moderate low (2000–2500 g) | 14 | −0.07 (−0.12 to −0.03) | <0.01 | 17.2 | 15 | −0.11 (−0.20 to −0.02) | 0.03 | 64.0 | 5 | −0.05 (−0.10 to 0.01) | 0.20 | 29.6 |
| Very low (<2000 g) | 14 | −0.27 (−0.49 to −0.07) | 0.02 | 74.0 | 13 | −0.26 (−0.40 to −0.12) | <0.01 | 74.9 | 5 | −0.28 (−0.60 to 0.05) | 0.17 | 81.1 |
|
| ||||||||||||
| Term (≥37 weeks) | Reference | Reference | Reference | |||||||||
| Late preterm (34–37 weeks) | 8 | −0.21 (−0.39 to −0.04) | 0.04 | 69.8 | 8 | −0.14 (−0.33 to 0.04) | 0.17 | 74.5 | 5 | −0.05 (−0.23 to 0.13) | 0.64 | 72.1 |
| Early preterm (<34 weeks) | 8 | −0.16 (−0.34 to 0.31) | 0.15 | 53.5 | 7 | −0.26 (−0.53 to 0.006) | 0.10 | 65.0 | 4 | −0.20 (−0.55 to 0.15) | 0.35 | 75.4 |
|
| ||||||||||||
| AGA (≥10 percentile) | Reference | Reference | Reference | |||||||||
| Moderate SGA (3–<10 percentile) | 8 | −0.05 (−0.11 to 0.12) | 0.16 | 0.0 | 9 | −0.01 (−0.10 to 0.07) | 0.77 | 36.6 | 4 | −0.06 (−0.18 to 0.06) | 0.40 | 29.4 |
| Severe SGA (<3 percentile) | 8 | −0.09 (−0.24 to 0.07) | 0.30 | 72.0 | 9 | 0.02 (−0.09 to 0.12) | 0.78 | 37.4 | 4 | 0.03 (−0.13 to 0.19) | 0.73 | 37.7 |
|
| ||||||||||||
| Term-AGA | Reference | Reference | Reference | |||||||||
| Preterm-AGA | 8 | −0.14 (−0.24 to −0.05) | 0.02 | 17.0 | 9 | −0.23 (−0.42 to −0.03) | 0.05 | 76.5 | 4 | −0.02 (−0.23 to 0.19) | 0.87 | 78.0 |
| Term-SGA | 8 | −0.02 (−0.10 to 0.06) | 0.66 | 44.6 | 9 | −0.007 (−0.08 to 0.06) | 0.84 | 31.4 | 4 | −0.03 (−0.12 to 0.06) | 0.55 | 9.3 |
| Preterm-SGA | 5 | −0.17 (−0.29 to −0.05) | 0.05 | 0.0 | 5 | −0.15 (−0.40 to 0.09) | 0.29 | 53.1 | 3 | n/a | n/a | n/a |
|
| ||||||||||||
| Yes | Reference | Reference | Reference | |||||||||
| No | 4 | −0.02 (−0.08 to 0.04) | 0.60 | 0.0 | 4 | −0.05 (−0.13 to 0.04) | 0.36 | 16.4 | 3 | n/a | n/a | n/a |
|
| ||||||||||||
| Normal (≥110 g/L) | Reference | Reference | Reference | |||||||||
| Mild anaemia (100–109 g/L) | 9 | −0.06 (−0.13 to 0.01) | 0.14 | 27.7 | 9 | −0.03 (−0.13 to 0.07) | 0.54 | 51.2 | 3 | n/a | n/a | n/a |
| Moderate anaemia (70–99 g/L) | 9 | −0.11 (−0.12 to −0.10) | <0.01 | 0.0 | 9 | −0.18 (−0.28 to −0.09) | <0.01 | 49.0 | 3 | n/a | n/a | n/a |
|
| ||||||||||||
| Yes | Reference | Reference | Reference | |||||||||
| No | 8 | −0.10 (−0.12 to −0.09) | <0.01 | 0.0 | 8 | −0.07 (−0.16 to 0.01) | 0.14 | 71.0 | 4 | −0.15 (−0.35 to 0.05) | 0.23 | 82.5 |
|
| ||||||||||||
| Yes | Reference | Reference | Reference | |||||||||
| No | 8 | −0.13 (−0.18 to −0.07) | <0.01 | 47.5 | 8 | −0.10 (−0.19 to -0.01) | 0.05 | 82.8 | 4 | −0.12 (−0.27 to 0.03) | 0.21 | 92.4 |
|
| ||||||||||||
| Yes | 5 | −0.02 (−0.16 to 0.13) | 0.84 | 66.8 | 5 | −0.02 (−0.14 to 0.09) | 0.71 | 62.8 | 2 | n/a | n/a | n/a |
| No | Reference | Reference | Reference | |||||||||
*Adjusted for child’s gender and age, mother’s education and household wealth.
†Adjusted for small for gestational age.
‡Adjusted for gestational age.
AGA, appropriate for gestational ageSGA, small for gestational age; SMD, standardised mean difference.